Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kinnate Biopharma Inc. (KNTE)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 43,711,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kinnate is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for genomically defined cancers. Co.'s focus is on three patient populations: those with cancers that harbor known oncogenic drivers with no available targeted therapies; those with genomically well-characterized tumors that have resistance to available treatments; and those whose tumors have acquired resistance over the course of therapy to available treatments. Co.'s product candidates are KIN002787, which is for the treatment of patients with lung cancer, melanoma and other solid tumors; and KIN-3248, which is targeting cancer-associated alterations in FGFR2.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 9,292,200
Total Buy Value $0 $0 $0 $25,488,272
Total People Bought 0 0 0 4
Total Buy Transactions 0 0 0 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 62
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Orbimed Capital Llc Director   –       •       •   2023-05-04 4 B $2.75 $1,319,750 I/I 479,909 877,827 2.25     -
   Orbimed Capital Llc Director   –       •       •   2023-05-02 4 B $2.67 $903,160 I/I 338,262 794,368 2.25     -
   Gordon Carl L Director   –       •       •   2023-05-02 4 B $2.67 $903,160 I/I 338,262 794,368 2.25     -
   Orbimed Capital Llc Director   –       •       •   2023-05-01 4 B $2.62 $1,876,331 I/I 716,157 735,542 2.25     -
   Gordon Carl L Director   –       •       •   2023-05-01 4 B $2.62 $1,876,331 I/I 716,157 735,542 2.25     -
   Orbimed Capital Llc Director   –       •       •   2023-04-28 4 B $2.55 $894,410 I/I 350,749 610,997 2.25     -
   Gordon Carl L Director   –       •       •   2023-04-28 4 B $2.55 $894,410 I/I 350,749 610,997 2.25     -
   Williams Richard Thomas Chief Medical Officer   •       –      –    2023-03-01 4 D $5.21 $3,324 D/D (638) 67,295     -
   Meltz Mark A COO General Counsel Secretary   •       –      –    2023-03-01 4 D $5.21 $3,324 D/D (638) 27,286     -
   Krishnamohan Neha Chief Financial Officer   •       –      –    2023-03-01 4 D $5.21 $8,966 D/D (1,721) 67,378     -
   Orbimed Advisors Iv Ltd Director   –       •       •   2023-02-17 3 IO $0.00 $0 I/I 0 1,100,000     -
   Orbimed Capital Llc Director   –       •       •   2023-02-17 4 A $0.00 $0 I/I 1,100,000 550,000     -
   Tananbaum James B. Director   –       •       •   2023-02-17 4 A $0.00 $0 I/I 1,100,000 1,975,001     -
   Gordon Carl L Director   –       •       •   2023-02-17 4 A $0.00 $0 I/I 1,100,000 550,000     -
   Foresite Capital Opportunity Management V, Llc 10% Owner   –       –       •   2023-02-17 4 A $0.00 $0 I/I 1,100,000 1,975,001     -
   Meltz Mark A COO General Counsel Secretary   •       –      –    2022-12-01 4 D $7.75 $4,193 D/D (541) 27,924     -
   Krishnamohan Neha Chief Financial Officer   •       –      –    2022-12-01 4 D $7.75 $11,307 D/D (1,459) 69,099     -
   Williams Richard Thomas Chief Medical Officer   •       –      –    2022-12-01 4 D $7.75 $4,193 D/D (541) 67,933     -
   Krishnamohan Neha Chief Financial Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 67,500 69,015     -
   Meltz Mark A COO General Counsel Secretary   •       –      –    2022-09-01 4 A $0.00 $0 D/D 25,000 28,465     -
   Williams Richard Thomas Chief Medical Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 25,000 68,474     -
   Williams Richard Thomas Chief Medical Officer   •       –      –    2022-03-14 4 B $8.37 $209,250 D/D 25,000 42,333 2.74     -
   Williams Richard Thomas Chief Medical Officer   •       –      –    2022-03-11 4 B $8.64 $129,600 D/D 15,000 17,333 2.74     -
   Gordon Carl L Director   –       •      –    2022-02-15 4 B $9.96 $89,640 I/I 9,000 3,509,030 2.1     -
   Orbimed Capital Llc Director   –       •      –    2022-02-15 4 B $9.96 $89,640 I/I 9,000 3,509,030 2.1     -
  62 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us